| Angela M Henderlong, APRN | |
|
2660 Sw 3rd St, Topeka, KS 66606-2442 | |
| (785) 354-9591 | |
| Not Available |
| Full Name | Angela M Henderlong |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 2660 Sw 3rd St, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003311887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 115605 (Kansas) | Secondary |
| 363L00000X | Nurse Practitioner | 78024 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Manhattan Surgical Hospital Llc | Manhattan, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
According to new research in the U.S., the most common form of blindness in the elderly, age-related macular degeneration (AMD), can be attributed to just two genes which trigger the condition.
Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
› Verified 4 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
According to new research in the U.S., the most common form of blindness in the elderly, age-related macular degeneration (AMD), can be attributed to just two genes which trigger the condition.
Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela M Henderlong, APRN 2660 Sw 3rd St, Topeka, KS 66606-2442 Ph: (785) 354-9591 | Angela M Henderlong, APRN 2660 Sw 3rd St, Topeka, KS 66606-2442 Ph: (785) 354-9591 |
News Archive
Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
According to new research in the U.S., the most common form of blindness in the elderly, age-related macular degeneration (AMD), can be attributed to just two genes which trigger the condition.
Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
› Verified 4 days ago
Jamuna A Jackson, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 823 Sw Mulvane St Fl 4, Topeka, KS 66606 Phone: 785-354-9591 | |
Natasha Marie Plank, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111 | |
Mrs. Lalitha Rao, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111 | |
Heather J. Ungeheuer, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 901 Sw Garfield Ave, Topeka, KS 66606 Phone: 785-354-5598 Fax: 785-354-5396 | |
Crystal Lea Clark, APRN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-295-8000 Fax: 785-295-5483 | |
Mrs. Megan Sommer, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2909 Se Walnut Dr, Topeka, KS 66605 Phone: 785-270-0047 |